M. Sagi

发表

Identification of mutations causing inherited retinal degenerations in the israeli and palestinian populations using homozygosity mapping.

Dikla Bandah-Rozenfeld, D. Sharon, E. Banin, 2014, Investigative ophthalmology & visual science.

Familial hydrocephalus of prenatal onset.

J. Zlotogora, M. Sagi, T. Cohen, 1994, American journal of medical genetics.

A BRCA1 Frame Shift Mutation in Women of Kurdish Jewish Descent

A. Zick, Y. Goldberg, T. Peretz, 2015 .

The 8765delAG mutation in BRCA2 is common among Jews of Yemenite extraction.

H. Gutman, I. Lerer, D. Abeliovich, 1998, American journal of human genetics.

Genetic counselling in familial Mediterranean fever: has the time come?

E. Ben-Chetrit, M. Sagi, 2001, Rheumatology.

Cancer genetic testing and assisted reproduction.

K. Offit, S. Cummings, K. Kohut, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A deletion/insertion mutation in the BRCA2 gene in a breast cancer family: A possible role of the Alu‐polyA tail in the evolution of the deletion

L. Kadouri, I. Lerer, D. Abeliovich, 2001, Genes, chromosomes & cancer.

A deletion mutation in GJB6 cooperating with a GJB2 mutation in trans in non‐syndromic deafness: A novel founder mutation in Ashkenazi Jews

I. Lerer, D. Abeliovich, M. Sagi, 2001, Human mutation.

Carrier screening for Gaucher disease: lessons for low-penetrance, treatable diseases.

A. Lahad, A. Orr-Urtreger, L. Peleg, 2007, JAMA.

Application of the Health Belief Model in a study on parents' intentions to utilize prenatal diagnosis of cleft lip and/or palate.

S. Shiloh, M. Sagi, T. Cohen, 1992, American journal of medical genetics.

Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations

K. Offit, L. Rubin, Y. Kemel, 2012, Cancer.

A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer

D. Bercovich, A. Nissan, L. Kadouri, 2007, BMC Cancer.

Genetic counseling for women with breast cancer: the importance of evaluating the spouse

T. Peretz, M. Sagi, T. Allweis, 2004, Clinical genetics.

Acceptance of Preventive Surgeries by Israeli Women Who had Undergone BRCA Testing

T. Peretz, V. Kram, M. Sagi, 2006, Familial Cancer.

Neurofibromatosis type I (NFI) in Israeli families: linkage analysis as a diagnostic tool.

I. Lerer, D. Abeliovich, J. Zlotogora, 1994, American journal of medical genetics.

Ethical Aspects of Genetic Screening in Israel

M. Sagi, 1998, Science in Context.

Patients’ Attitudes Towards Disclosure of Genetic Test Results to Family Members: The Impact of Patients’ Sociodemographic Background and Counseling Experience

E. Pras, R. Spiegel, S. Shalev, 2016, Journal of Genetic Counseling.

Genetic testing of breast and ovarian cancer patients: clinical characteristics and hormonal risk modifiers.

I. Lerer, D. Abeliovich, T. Peretz, 1999, European journal of obstetrics, gynecology, and reproductive biology.

Clinical-biochemical correlation in molecularly characterized patients with Niemann-Pick type C

H. Mandel, R. Carmi, V. Meiner, 2001, Genetics in Medicine.

Preimplantation genetic diagnosis for BRCA1/2—a novel clinical experience

M. Werner, E. Girsh, D. Abeliovich, 2009, Prenatal diagnosis.

Sporadic breast cancer among relatives of BRCA mutation carriers

T. Peretz, M. Sagi, T. Allweis, 2005, Genetics in Medicine.

Cystic fibrosis mutations in Israeli Arab patients

I. Lerer, D. Abeliovich, J. Rivlin, 1999, Human mutation.

Cystic fibrosis mutations AF508 and G542X in Jewish patients

I. Lerer, G. Cutting, D. Abeliovich, 2022 .

Complete remission, in BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma, treated with cisplatin based therapy

L. Kadouri, Y. Goldberg, T. Peretz, 2011, Cancer biology & therapy.

Establishment in continuous culture of a T‐lymphoid cell line (HD‐Mar) from a patient with Hodgkin's lymphoma

A. Polliack, S. Mitrani‐Rosenbaum, M. Sagi, 1980, International journal of cancer.

[Can we improve the content and quality of information delivered prior to amniocentesis?].

M. Brezis, M. Sagi, M. Granat, 2008, Harefuah.

Acceptance of preventive surgeries by Israeli women who had undergone BRCA testing

V. Kram, M. Sagi, Tamar Perez, 2006, Familial Cancer.

Fanconi anemia: prenatal diagnosis in 30 fetuses at risk.

A. Auerbach, M. Sagi, B. Adler, 1985, Pediatrics.

Lynch Syndrome in high risk Ashkenazi Jews in Israel

A. Nissan, H. Baris, I. Lerer, 2014, Familial Cancer.

Attitudes of couples identified through screening as carriers of Gaucher disease type 1

A. Lahad, M. Sagi, E. Levy-Lahad, 2008, Clinical genetics.

Prenatal diagnosis of sex chromosome aneuploidy: possible reasons for high rates of pregnancy termination

V. Meiner, J. Zlotogora, M. Sagi, 2001, Prenatal diagnosis.

Clinical and genetic heterogeneity of congenital adrenal hypoplasia due to NR0B1 gene mutations

A. Eliakim, Y. Anikster, J. Sack, 2010, Clinical endocrinology.

Anorectal malformations and Down syndrome.

O. Lernau, J. Zlotogora, M. Sagi, 1989, American journal of medical genetics.

A novel MLH1 mutation harbored as a germ line aberration by a young woman of an HNPCC-like family and exhibited by a CML patient when occurring prior to the initiation of the blast phase concomitant with a c-MYC amplification.

Lucy Leshanski, D. Amikam, M. Sagi, 2006, International journal of molecular medicine.

The R245X Mutation of PCDH15 in Ashkenazi Jewish Children Diagnosed with Nonsyndromic Hearing Loss Foreshadows Retinitis Pigmentosa

M. Hildesheimer, T. Friedman, K. Avraham, 2004, Pediatric Research.

Genetic screening in patients with Retinoblastoma in Israel

I. Lerer, D. Abeliovich, J. Pe’er, 2015, Familial Cancer.

The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.

I. Lerer, D. Abeliovich, T. Peretz, 1997, American journal of human genetics.

The Effect of Genetic Counseling on Knowledge and Perceptions Regarding Risks for Breast Cancer

T. Peretz, J. Zlotogora, M. Sagi, 1998, Journal of Genetic Counseling.

Language in boys with fragile X syndrome.

Y. Levy, M. Frydman, M. Sagi, 2006, Journal of child language.

Genetic predisposition to radiation induced sarcoma: possible role for BRCA and p53 mutations

L. Kadouri, I. Lerer, Y. Goldberg, 2013, Breast Cancer Research and Treatment.

An Ashkenazi founder mutation in the PKHD1 gene.

S. Carmi, H. Daum, I. Lerer, 2016, European journal of medical genetics.

Mutation spectrum in Jewish cystic fibrosis patients in Israel: Implication to carrier screening

I. Lerer, D. Abeliovich, M. Sagi, 2005, American journal of medical genetics. Part A.

Deletion of the ANKRD15 gene at 9p24.3 causes parent-of-origin-dependent inheritance of familial cerebral palsy.

I. Lerer, V. Meiner, D. Abeliovich, 2005, Human molecular genetics.

Uniparental disomy in fetuses diagnosed with balanced Robertsonian translocations: risk estimate

I. Lerer, A. Frumkin, D. Abeliovich, 2002, Prenatal diagnosis.

Genotype-phenotype correlation in the presentation of retinoblastoma among 149 patients.

J. Pe’er, M. Sagi, Ofira Zloto, 2016, Experimental eye research.

Enhancement of carcinogen-induced chromosome breakage and sister chromatid exchange by 13-cis-retinoic acid.

A. Auerbach, M. Sagi, D. M. Carter, 1984, Basic life sciences.

FRAMING OF PRENATAL SCREENING TEST ORIENTATIONS AS DETERMINANTS OF PERCEPTIONS OF FETAL HEALTH AND APPROVAL OF AMNIOCENTESIS* RESULTS AND WOMEN'S HEALTH-ILLNESS

S. Shiloh, M. Sagi, Naomi Jaffe Eini, 2007 .

framing of prenatal screening test results and women's health-illness orientations as determinants of perceptions of fetal health and approval of amniocentesis

Shoshana Shiloh, S. Shiloh, M. Sagi, 2001 .

"My funky genetics": BRCA1/2 mutation carriers' understanding of genetic inheritance and reproductive merger in the context of new reprogenetic technologies.

L. Rubin, M. Sagi, K. Hurley, 2012, Families, systems & health : the journal of collaborative family healthcare.

Preimplantation genetic diagnosis for cancer syndromes: a new challenge for preventive medicine.

K. Offit, M. Sagi, K. Hurley, 2006, JAMA.

On not wanting to know and not wanting to inform others: choices regarding predictive genetic testing

Ilan Yaniv, M. Sagi, 2004 .

Spectrum of genes for inherited hearing loss in the Israeli Jewish population, including the novel human deafness gene ATOH1

T. Walsh, M. King, N. Shomron, 2020, bioRxiv.

Genome‐wide SNP genotyping identifies the Stereocilin (STRC) gene as a major contributor to pediatric bilateral sensorineural hearing impairment

Joseph T. Glessner, I. Krantz, N. Spinner, 2012, American journal of medical genetics. Part A.

Response to ACMG guideline: Carrier screening in individuals of Ashkenazi Jewish decent

E. Levy-Lahad, M. Sagi, S. Zuckerman, 2008, Genetics in Medicine.

The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types.

J. Zlotogora, M. Sagi, T. Cohen, 1983, American journal of human genetics.

Syndrome of tetraamelia with pulmonary hypoplasia.

J. Zlotogora, M. Sagi, Y. O. Shabany, 1993, American journal of medical genetics.

Cystic fibrosis mutations delta F508 and G542X in Jewish patients.

G. Cutting, I. Lerer, D. Abeliovich, 1992, Journal of medical genetics.

Genetic Counseling Services and Training of Genetic Counselors in Israel: An Overview

W. Uhlmann, M. Sagi, 2013, Journal of Genetic Counseling.

Further localization of X-linked hydrocephalus in the chromosomal region Xq28.

S. Warren, C. Broeckhoven, B. Wittwer, 1992, American journal of human genetics.

XX/XY lymphoid chimerism in a boy with fatal lymphohistiocytic proliferation.

U. Galili, M. Sagi, C. Brautbar, 1981, JAMA.

Effect of framing on the perception of genetic recurrence risks.

S. Shiloh, M. Sagi, S Shiloh, 1989, American journal of medical genetics.

Whole Exome Sequencing Reveals Mutations in Known Retinal Disease Genes in 33 out of 68 Israeli Families with Inherited Retinopathies

I. Chowers, S. Jacobson, A. Swaroop, 2015, Scientific Reports.

The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer.

O. Manor, I. Lerer, D. Abeliovich, 1999, American journal of human genetics.

Origin of an 84-kDa protein with ABH blood-typing antigen activity in human seminal plasma.

M. Sagi, K. Ito, A. Nakamura, 1999, Journal of andrology.

The property of ABO blood group antigen on sperm.

M. Sagi, M. Kitahama, I. Sato, 1987, Nihon hoigaku zasshi = The Japanese journal of legal medicine.

Genetic screening in patients with Retinoblastoma in Israel

I. Lerer, D. Abeliovich, J. Pe’er, 2015, Familial Cancer.

Presentation Format Affects Comprehension and Risk Assessment: The Case of Prenatal Screening

Y. Hanoch, T. Miron-Shatz, M. Sagi, 2009, Journal of health communication.

Mutation spectrum in HNPCC in the Israeli population

E. Pikarski, D. Bercovich, A. Nissan, 2008, Familial Cancer.

Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations

Ayala Hubert, L. Kadouri, D. Abeliovich, 2007, Journal of Medical Genetics.

Genetic testing for hearing loss: different motivations for the same outcome.

M. Sagi, H. Hochner, H. Levi, 2002, American journal of medical genetics.

Contribution of connexin 26 mutations to nonsyndromic deafness in Ashkenazi patients and the variable phenotypic effect of the mutation 167delT.

I. Lerer, D. Abeliovich, M. Sagi, 2000, American journal of medical genetics.

Ataxia telangiectasia: chromosomal stability in continuous lymphoblastoid cell lines.

M. Cohen, M. Sagi, H. Ben-bassat, 1979, Cytogenetics and cell genetics.

Extended Phenotype in the Transthyretin Tyr77 Familial Amyloid Polyneuropathy

O. Abramsky, S. Hassin-Baer, D. Soffer, 2005, European Neurology.

Variability of Stickler syndrome.

J. Zlotogora, M. Sagi, H. Leiba, 1992, American journal of medical genetics.

Gaucher disease type I and pregnancy.

J. Zlotogora, M. Sagi, M. Zeigler, 1989, American journal of medical genetics.

Two BRCA1/2 founder mutations in Jews of Sephardic origin

D. Bercovich, I. Lerer, Y. Goldberg, 2011, Familial Cancer.

‘The BRCA Clock is Ticking!’: Negotiating medical concerns and reproductive goals in preimplantation genetic diagnosis

L. Rubin, M. Sagi, K. Hurley, 2014, Human fertility.

Presentation Format Affects Comprehension and Risk Assessment: The Case of Prenatal Screening

Y. Hanoch, T. Miron-Shatz, M. Sagi, 2009, Journal of health communication.

Prevalence of myotonic dystrophy in Israeli Jewish communities: Inter‐community variation and founder premutations

Y. Shapira, A. Korczyn, I. Lerer, 2003, American journal of medical genetics. Part A.

Preimplantation exclusion of embryos at risk for prion diseases

V. Meiner, E. Aizenman, N. Weinberg, 2006, Neurology.

Lynch Syndrome in high risk Ashkenazi Jews in Israel

A. Nissan, H. Baris, I. Lerer, 2013, Familial Cancer.